Data from RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response
Authors:
- Inês GomesIGInês Gomes
- Maria MarteloMMMaria Martelo
- Rúben D. VilelaRVRúben D. Vilela
- María JiménezMJMaría Jiménez
- Eva M. TrinidadETEva M. Trinidad
- Jorge Gómez-MiragayaJGJorge Gómez-Miragaya
- Eva González-SuárezEGEva González-Suárez
- Érica MartinsÉMÉrica Martins
- Sofia S. TorresSTSofia S. Torres
- Patrícia CorredeiraPCPatrícia Corredeira
- Joana L. MirandaJMJoana L. Miranda
- André MansinhoAMAndré Mansinho
Open Access
- 3 November 2025
- other
- Published by American Association for Cancer Research (AACR)